NHLBI trial concludes no benefit for hydroxychloroquine in COVID-19
(HealthDay)—Hydroxychloroquine is not beneficial for adults hospitalized with COVID-19, according to the formal conclusion of a study funded by the U.S. National Heart, Lung, and Blood Institute (NHLBI) and published online ...